April 13-16 | Rotterdam, NL
April 13-16 | Rotterdam, NL
April 13-16 | Rotterdam, NL
April 13-16 | Rotterdam, NL
April 13-16 | Rotterdam, NL
ECIO meets ILCA
ECIO meets ILCA session
Moderators: L. Crocetti (Pisa/IT), T. Meyer (London/GB)
Welcome by the moderators
Endpoints in clinical trials for intermediate and early stage HCC – lessons from recent trials
M. Reig (Barcelona/ES)
Downstaging and bridging in liver transplantation for HCC – still a hot topic
L. Crocetti (Pisa/IT)
Radiogenomics for cholangiocarcinoma
L. Viganò (Bergamo/IT)
Interventional treatment for intra-hepatic cholangiocarcinoma
B. Guiu (Montpellier/FR)
Panel discussion and conclusion
About ILCA
The International Liver Cancer Association is the only international organisation devoted exclusively to liver cancer research for experts from all related disciplines. Its mission is to lead a global community of physicians, scientists and allied professionals through education and research with the goal to better prevent and treat liver cancer. It does so by promoting novel pathogenic, diagnostic, and therapeutic interventions for liver cancer by taking a transversal approach to research and bring together scientists, physicians, and allied professionals from all interrelated fields.